133 related articles for article (PubMed ID: 12511205)
1. In vitro permeation screening of a new formulation of thiocolchicoside containing various enhancers.
Ceschel GC; Maffei P; Porzio S; Melillo G; Caselli GF; Dragani MC; Gentile MM; Clavenna G
Drug Deliv; 2002; 9(4):259-63. PubMed ID: 12511205
[TBL] [Abstract][Full Text] [Related]
2. Vehicle effects on in vitro skin permeation of thiocolchicoside.
Bonina F; Puglia C; Trombetta D; Dragani MC; Gentile MM; Clavenna G
Pharmazie; 2002 Nov; 57(11):750-2. PubMed ID: 12611278
[TBL] [Abstract][Full Text] [Related]
3. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
4. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro.
Artusi M; Nicoli S; Colombo P; Bettini R; Sacchi A; Santi P
J Pharm Sci; 2004 Oct; 93(10):2431-8. PubMed ID: 15349953
[TBL] [Abstract][Full Text] [Related]
5. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
7. Penetration and distribution of thiocolchicoside through human skin: comparison between a commercial foam (Miotens) and a drug solution.
Aguzzi C; Rossi S; Bagnasco M; Lanata L; Sandri G; Bona F; Ferrari F; Bonferoni MC; Caramella C
AAPS PharmSciTech; 2008; 9(4):1185-90. PubMed ID: 19051040
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
9. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
11. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
12. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
13. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies.
Artusi M; Santi P; Colombo P; Junginger HE
Int J Pharm; 2003 Jan; 250(1):203-13. PubMed ID: 12480286
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.
Mura P; Faucci MT; Bramanti G; Corti P
Eur J Pharm Sci; 2000 Feb; 9(4):365-72. PubMed ID: 10664476
[TBL] [Abstract][Full Text] [Related]
16. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium.
Maurya A; Murthy SN
J Pharm Sci; 2014 May; 103(5):1497-503. PubMed ID: 24644068
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations.
Ustündağ Okur N; Apaydın S; Karabay Yavaşoğlu NÜ; Yavaşoğlu A; Karasulu HY
Int J Pharm; 2011 Sep; 416(1):136-44. PubMed ID: 21723930
[TBL] [Abstract][Full Text] [Related]
19. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
20. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions.
Pireddu R; Sinico C; Ennas G; Schlich M; Valenti D; Murgia S; Marongiu F; Fadda AM; Lai F
Colloids Surf B Biointerfaces; 2018 Feb; 162():8-15. PubMed ID: 29132043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
